KarenEAgersborgDOFACOI, FACE

Endocrinology • Cape May Court House, NJ

Diabetes, Lipid Metabolism, Thyroid

CLINICAL ENDOCRINOLOGIST

Join to view full profile

Dr. Agersborg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Agersborg's full profile

Already have an account?

Office
Cape Regional Medical Center
11 Village Drive
Cape May Court House, NJ 08210
Phone+1 609-465-2273

Summary

Dr. Karen Agersborg is an endocrinologist in Cape May Court, New Jersey. She received her medical degree from Philadelphia College of Osteopathic Medicine and has been in practice > 20 years . She specializes in Endocrinology , Diabetes and Metabolism. She practices all aspects of Endocrinology.

Education & Training

Temple University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2002 - 2004
Philadelphia College of Osteopathic MedicineClass of 1998

Certifications & Licensure

PA State License 1999 - 2026
NJ State License 2000 - 2025
VA State License 2004 - 2006
AOA Board of Internal Medicine Endocrinology
AOA Board of Internal Medicine Internal Medicine
Osteopathic Board Certified Endocrinology, Diabetes, MetabolismEndocrinology, Diabetes, Metabolism

Awards, Honors, & Recognition

Fellow (FACE) American Association of Clinical Endocrinology, 2007
CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012
Fellow, (FACOI) American College of Osteopathic Internanists, 2004

Committees

Committee Member, Women in Medicine 2007 - 2010
Committee Member, Bylaws 2007 - 2008
Committee Member Endocrinology, Chief’s Committee 2005 - 2010
Committee Member, Investigational Review Board 2004 - 2006

Professional Memberships

Industry Relationships

Non- Executive Director/ Board of Directors, Clinuvel Pharmaceuticals Ltd.2018 - Present